Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New ovine enzootic abortion vaccine in development
"We are very encouraged by the new vaccine results." - Dr David Longbottom.
The work is led by Dr David Longbottom, of the Moredun Research Institute. 

Scientists at the Moredun Research Institute are developing a new vaccine against ovine enzootic abortion.

Ovine enzootic abortion is the most common cause of abortion in sheep in the UK, and is caused by the bacteria Chlamydia abortus, which invades the placenta during pregnancy. The disease can also cause life-threatening illness and abortion in humans.

The disease spreads through ingestion and inhalation, and a high level of environmental contamination by infected ewes in lambing pens is a key point in the spread of disease.

Led by Dr David Longbottom, the scientists at Moredun have completed the first stage in the development of the vaccine, which is similar to the live variation, but does not possess the ability to grow and cause infections in the host animal. 

Dr Longbottom commented on the ongoing development process: “We are very encouraged that the new vaccine results in a similar protective response to that generated following a natural infection or resulting from the live vaccines but importantly without the ability to cause disease.”

More about the vaccine can be read in this study, published in Vaccines

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.